BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6113532)

  • 1. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
    Müller G; Uberbacher HJ; Glocke M
    Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
    Bernat AC; Riera de Barcia L
    Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effect of metipranolol on ischemic heart muscle.
    Gvozdják J; Gvozdjáková A; Kucharská J; Bada V
    Cardiology; 1989; 76(3):206-10. PubMed ID: 2570631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blockers plus isosorbide-5-mononitrate for prevention of esophageal variceal rebleeding: a systematic review].
    Sun XB; Wang Q; Shi W
    Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):632-3. PubMed ID: 18752758
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
    Nedvídková J; Cenková V; Felt V
    Cas Lek Cesk; 1980 Jul; 119(27-28):749-51. PubMed ID: 6107177
    [No Abstract]   [Full Text] [Related]  

  • 10. [Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol].
    Gill E; Bechler M; Forst HT
    ZFA (Stuttgart); 1980 May; 56(14):1037-44. PubMed ID: 7415470
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isosorbide mononitrate or dinitrate in coronary disease?].
    Schanzenbächer P; Kochsiek K
    Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
    Kolloch R; Overlack A; Stumpe KO
    Ther Ggw; 1979 Oct; 118(10):1517-28. PubMed ID: 40314
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
    Herbaczyńska-Cedro K; Woźniewicz B; Broniszewska-Ardelt B; Ceremuzyński L
    Cardiology; 1981; 67(4):206-18. PubMed ID: 6113891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
    Raff U; Jeschke D
    Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
    Hanania G; Haïat R; Olive T; Maalouf B; Michel D; Martelet M; Godard S;
    Ann Cardiol Angeiol (Paris); 2002 Nov; 51(5):268-74. PubMed ID: 12515103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
    Smíd J; Hůla J; Kubín Z
    Vnitr Lek; 1983 Apr; 29(4):325-31. PubMed ID: 6135276
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trials in pressure regulation with metipranolol eyedrops in special forms of glaucoma in ophthalmologic practice].
    Demmler N
    Klin Monbl Augenheilkd; 1983 Feb; 182(2):153-5. PubMed ID: 6133028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metipranolol in the prevention of intraocular pressure elevation after cataract extraction].
    Schmitz-Valckenberg P
    Klin Monbl Augenheilkd; 1983 Feb; 182(2):150-2. PubMed ID: 6133027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.